Poster Presented at DERM 2025: High Impact Areas See Positive Results in Icotrokinra Phase 3 Trial

Psoriasis in high impact areas responded well to icotrokinra, presenting a potential exciting option for patients.

Source: www.dermatologytimes.com

Categories: Dermatology, General Medicine News

Tags: dermNPPA,DERM2025

Tweets with this article

Dermatology Times

👥🎰🎲 James Song, MD, shares insights into a poster presented at #dermNPPA demonstrating that treatment with icotrokinra resulted in higher rates of psoriasis clearance in high impact areas when compared with placebo. #DERM2025 https://t.co/MYlMwsSLBj

Beyond the Surface: Walter Liszewksi, MD, on New Frontiers in Chronic Skin Conditions

Discover Walter Liszewksi, MD’s insights on emerging therapies and consumer safety at Elevate-Derm Summer 2025, focusing on allergy research and treatment advancements.

Dermatology Times July 25, 2025

Lawrence Schachner, MD, Reflects on Career, Mentorship, and Innovation

Schachner was the 2025 recipient of the AAP Alvin H. Jacobs award at the 50th annual SPD meeting.

Dermatology Times July 25, 2025

TNF Inhibitors Improve Clinical Outcomes in csDMARD-Inadequate Psoriatic Arthritis, Review Finds

For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.

The Dermatologist July 25, 2025

Current Issue Table of Contents: Journal of Investigative Dermatology

Your session will expire shortly. If you are still working, click the ‘Keep Me Logged In’ button below. If you do not respond within the…

JIDJournal July 25, 2025

Expanding Treatment Options to Pediatric Populations: A Conversation With Lisa Swanson, MD, at DERM 2025

Lisa Swanson, MD, discusses the unmet needs in pediatric dermatology at the DERM 2025 conference.

Dermatology Times July 25, 2025

Day 1 Recap: Elevate-Derm Summer Conference 2025

Catch up on coverage from the first day of the 2025 Elevate-Derm Summer Conference held in Park City, Utah.

Dermatology Times July 25, 2025

Forever Chemicals: Michelle Hure, MD, Discusses Clinical Concerns About PFAS in Dermatology

Dermatology Times connects dermatology professionals with key skin disorder coverage, therapeutic strategies, clinical trial updates, and expert insights.

Dermatology Times July 25, 2025

Postzygotic Gain-of-Function Variant in TRPM4 and Inflammatory Linear Verrucous Epidermal Nevus

This case report describes a young woman with diffuse pruritic erythematous plaques and papules since birth who presented with coalesced spiked keratotic papules on the…

JAMA Dermatology July 25, 2025

Home

Thursday, September 4, 2025 6:42 pm – 7:42 pm CDT Grand Ballroom A (Theater Room 1), Level 3 George R. Brown Convention Center | Houston,…

Medscape Dermatology July 25, 2025

Home

Saturday, August 9, 2025 5:30 pm – 7:00 pm MT Room: North Ballroom 120D Phoenix Convention Center | Phoenix, Arizona CME/CE In-Person Discover how the…

Medscape Dermatology July 25, 2025

Related Articles